Skip to main content
. Author manuscript; available in PMC: 2016 Apr 15.
Published in final edited form as: Cancer. 2014 Dec 23;121(8):1223–1230. doi: 10.1002/cncr.29175

Treatment Modifications Detail View

PCI-24781 Dose Levels: 0 = 30 mg/m2 1 = 60
mg/m2 2 = 90 mg/m2 3 = 120 mg/m2
Doxorubicin Dose Levels: 1 = 75 mg/m2 2
= 60mg/m2 3 = 45 mg/m2
PCI-24781 Treatment Doxorubicin Treatment
Dose
Level
Dose
Modifications
Number of
cycles
Dose
Level
Dose
Modifications
Number
of cycles
0 No modifications 2 1 No modifications 3
0 No modifications 5 1 No modifications 5
0 No modifications 10 1 No modifications 6
1 No modifications 1 1 No modifications 1
1 1 dose withheld 1 1 No modifications 1
1 No modifications 2 1 No modifications 2
1 1 dose modifcation to dose level 0, 10 doses withheld 6 1 No modifications 4
1 3 doses withheld 10 1 No modifications 6
1 No modifications 1 1 No modifications 1
1 1 dose modification to dose level 0 6 1 1 dose modification to dose level 2 6
2 No modifications 6 1 No modifications 6
2 1 dose modification 3 1 1 dose modification 3
2 1 dose missed 2 1 No modifications 2
2 No modifications 7 1 No modifications 6
2 1 dose withheld 2 1 No modifications 2
2 No modifications 2 1 No modifications 2
3 No modifications 1 1 No modifications 1
3 9 doses withheld and 1 dose modification to dose level 2 5 1 2 doses withheld and 1 dose modification in dose level 2 5
3 No modifications 4 1 No modifications 4
*
3 No modifications 2 1 No modifications 2
3 No modifications 1 1 No modifications 1
Summary:
Dose Level 0: No Modifications for 3 subjects
Dose Level 1: Modifications/holds for 4 out of 7 subjects
Dose Level 2: Modifications/holds for 3 out of 6 subjects
Dose Level 3: Modifications/holds for 1 out of 5 subjects
*

Patient’s data removed from analysis as patient withdrew consent 2 days after starting treatment.